Generics Group Says 'Skinny Label' Suit Should Not Proceed

By Britain Eakin (August 20, 2021, 10:11 PM EDT) -- The Association for Accessible Medicines has urged a Delaware federal judge to reject part of a magistrate judge's report and recommendation not to dismiss Amarin Pharma Inc.'s infringement suit against Hikma Pharmaceuticals USA Inc. over its heart drug Vascepa, saying that if the suit goes forward, patients will be forced to pay higher prices for branded drugs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!